amoxicillin-potassium-clavulanate-combination and Colitis--Ulcerative

amoxicillin-potassium-clavulanate-combination has been researched along with Colitis--Ulcerative* in 4 studies

Trials

1 trial(s) available for amoxicillin-potassium-clavulanate-combination and Colitis--Ulcerative

ArticleYear
Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis.
    Inflammatory bowel diseases, 1998, Volume: 4, Issue:1

    The inflammatory activity of colonic mucosal lesions may be stimulated by intraluminal bacteria. Our aim was to investigate whether administration of broad-spectrum antibiotics decreases inflammatory activity in ulcerative colitis. To this end, we performed a randomized, 5-day study with either oral enterically coated amoxicillin-clavulanic acid (1 g + 250 mg, t.i.d.); i.v. methylprednisolone (40 mg/day) and oral placebo (t.i.d.); or both i.v. methylprednisolone and oral amoxicillin-clavulanic acid as above, in 30 patients with clinically active ulcerative colitis. Before and after 5 days of treatment, intestinal inflammation was assessed by the quantification of mucosal release of eicosanoids and interleukin-8 by rectal dialysis in each patient. Breath H2 excretion after oral lactulose was determined as an index of metabolic activity of colonic flora. The total release of (IL-8) interleukin-8 and eicosanoids significantly decreased in patients treated with antibiotic or steroids and antibiotic. Antibiotic treatment, but not steroids, markedly inhibited breath H2 excretion. In conclusion, short-term treatment with enteric-coated amoxicillin-clavulanic acid decreases the intraluminal release of IL-8 and other inflammatory mediators.

    Topics: Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Inflammatory Agents; Colitis, Ulcerative; Drug Therapy, Combination; Eicosanoids; Female; Humans; Interleukin-8; Male; Methylprednisolone; Middle Aged; Tablets, Enteric-Coated

1998

Other Studies

3 other study(ies) available for amoxicillin-potassium-clavulanate-combination and Colitis--Ulcerative

ArticleYear
Pyoderma gangrenosum in ulcerative colitis - An exuberant and painful complication.
    Revista espanola de enfermedades digestivas, 2022, Volume: 114, Issue:12

    A 41-years-old female, with ulcerative colitis, presented to the emergency department with 7-days history of abdominal pain, bloody stools (> 10/day). The patient referred the appearance of a cutaneous lesion, on her left thigh, with subsequent appearance of similar lesions on the lower limbs. No improvement after amoxicillin/clavulanic acid. On admission, she was febrile (38.2 ÂșC) and tachycardic. She had three cutaneous lesions, the largest one with 8cm in the left thigh - a deep and painful lesion, with extensive ulceration, necrosis, exudative edges and with marked pathergia, compatible with pyoderma gangrenosum.

    Topics: Abdominal Pain; Adult; Amoxicillin-Potassium Clavulanate Combination; Colitis, Ulcerative; Female; Humans; Pyoderma Gangrenosum

2022
Concomitant hidradenitis suppurativa and pyostomatitis vegetans in silent ulcerative colitis successfully treated with golimumab.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:12

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Monoclonal; Colitis, Ulcerative; Female; Hidradenitis Suppurativa; Humans; Stomatitis

2016
Case records of the Massachusetts General Hospital. Case 14-2005. A 38-year-old man with fever and blurred vision.
    The New England journal of medicine, 2005, May-12, Volume: 352, Issue:19

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Biopsy; Colitis, Ulcerative; Colon; Diagnosis, Differential; Fever; Humans; Male; Pilonidal Sinus; Postoperative Complications; Purpura; Retinal Vasculitis; Skin; Thrombophlebitis; Vasculitis; Vision Disorders

2005